Aquestive Therapeutics
AQST
AQST
114 hedge funds and large institutions have $154M invested in Aquestive Therapeutics in 2024 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 33 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 117 → 114 (-3)
3.79% less ownership
Funds ownership: 51.37% → 47.57% (-3.8%)
34% less capital invested
Capital invested by funds: $232M → $154M (-$78M)
Holders
114
Holding in Top 10
2
Calls
$1.89M
Puts
$605K
Top Buyers
| 1 | +$2.33M | |
| 2 | +$2.21M | |
| 3 | +$1.79M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.17M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$1.08M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$2.63M | |
| 3 | -$2.25M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.74M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.65M |